JeffreyRSchriberMD

Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope

Overview of Dr. Schriber

Dr. Jeffrey Schriber is a hematologist in Goodyear, AZ and is affiliated with multiple hospitals in the area, including City of Hope Phoenix, HonorHealth Scottsdale Shea Medical Center, Chandler Regional Medical Center, HonorHealth Scottsdale Osborn Medical Center, and HonorHealth Scottsdale Thompson Peak Medical Center. He received his medical degree from University of Toronto Faculty of Medicine and has been in practice 31 years. Dr. Schriber accepts several types of health insurance, listed below. He is one of 9 doctors at HonorHealth Scottsdale Shea Medical Center and one of 4 doctors at HonorHealth Scottsdale Osborn Medical Center who specialize in Hematology. He has more than 50 publications and over 500 citings.

Office
14200 W. Celebrate Life Way.
Goodyear, AZ 85338
Book by Phone+1(602) 878-3063
Is this information wrong?

Education & Training

University of Toronto Faculty of MedicineClass of 1986
Stanford Health CareFellowship, Blood & Bone Marrow Transplant
University of TorontoResidency, Internal Medicine
University of TorontoFellowship, Internal Medicine, Toronto Canada, Royal College of Physicians and Surgeons Canada
University of TorontoFellowship, Hematology. Toronto Canada. Royal College of Physicians and Surgeons, Canada

Certifications & Licensure

CA State Medical License 1998 - 2025
NM State Medical License 2022 - 2025
AZ State Medical License 1997 - 2024
OK State Medical License 2023 - 2024
ID State Medical License 2023 - 2024
NY State Medical License 1994 - 1998
Canada's Royal College of Physicians and SurgeonsHematology
Canada's Royal College of Physicians and SurgeonsInternal Medicine

Clinical Trials

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Start of enrollment: 2003 Dec 01
Completed
Phase 3
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12
Completed
Phase 2
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2 Start of enrollment: 2021 Feb 08
Active, not recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

10 citations
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.
Rima M Saliba, Amin M Alousi, Joseph Pidala, Mukta Arora, Stephen R Spellman, Michael T Hemmer, Tao Wang, Camille Abboud, Sairah Ahmed, Joseph H Antin, Amer Beitinjane...> ;Transplantation and Cellular Therapy. 2022 Oct 1
3 citations
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
Joshua F. Zeidner, Tara L. Lin, Carlos E. Vigil, Gil Fine, M. Yair Levy, Aziz Nazha, Jordi Esteve, Daniel J. Lee, Karen W.L. Yee, Andrew Dalovisio, Eunice S. Wang, Jua...> ;Blood Cancer Journal. 2021 Oct 30
Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.
Dhakal, B., Patel, S., Girnius, S., Bachegowda, L., Fraser, R., Davila, O., Kanate, A., Assal, A., Hanbali, A., Bashey, A., Pawarode, A., Freytes, C., Lee, C., Vesole,...> ;Leukemia. 2021 Jul 1
42 citations
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma
Pashna N. Munshi, David H. Vesole, Artur Jurczyszyn, Jan Maciej Zaucha, Andrew St. Martin, Omar Davila, Vaibhav Agrawal, Sherif M. Badawy, Minoo Battiwalla, Saurabh Ch...> ;Cancer. 2020 Dec 1
26 citations
Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Leukemia. 2020 Apr 20
7 citations
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation
Betty K. Hamilton, Ying Liu, Michael T. Hemmer, Navneet S. Majhail, Olle Ringdén, Dennis Dong Hwan Kim, Luciano J. Costa, Robert K. Stuart, Amin M. Alousi, Joseph Pida...> ;Biology of Blood and Marrow Transplantation. 2019 Sep 1
6 citations
Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.
Michael A. Pulsipher, Brent R. Logan, Deidre M. Kiefer, Pintip Chitphakdithai, Marcie L. Riches, J. Douglas Rizzo, Paolo Anderlini, Susan F. Leitman, James W. Varni, H...> ;Biology of Blood and Marrow Transplantation. 2019 May 1
28 citations
ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.
Shahrukh K. Hashmi, Stephanie J. Lee, Bipin N. Savani, Linda J. Burns, John R. Wingard, Miguel-Angel Perales, Jeanne Palmer, Eric J. Chow, Everett Meyer, David I. Mark...> ;Biology of Blood and Marrow Transplantation. 2018 Jun 1
35 citations
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: A center for international blood and marrow transplant research a...
Anuj Mahindra, Parameswaran Hari, Raphael Fraser, Mingwei Fei, Jiaxing Huang, Jesus G. Berdeja, Natalie S. Callander, Luciano J. Costa, Miguel Angel Diaz, Cesar O. Fre...> ;Bone Marrow Transplantation. 2017 Sep 18
63 citations
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR r...
Jeffrey Schriber, Parameswaran Hari, Kwang Woo Ahn, Mingwei Fei, Luciano J. Costa, Mohamad A. Kharfan-Dabaja, Miguel Angel-Diaz, Robert Peter Gale, Siddharatha Ganguly...> ;Cancer. 2017 Aug 15
109 citations
Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee
Jeanne Palmer, Jeannine S. McCune, Miguel-Angel Perales, David I. Marks, Joseph S. Bubalo, Mohamad Mohty, John R. Wingard, Angelo Paci, Moustapha Hassan, Christopher B...> ;Biology of Blood and Marrow Transplantation. 2016 Nov 1
85 citations
Primary Graft Failure after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
Richard F. Olsson, Brent R. Logan, Sonali Chaudhury, Xiaochun Zhu, Gorgun Akpek, Brian J. Bolwell, Christopher Bredeson, Christopher C. Dvorak, Vikas Gupta, Vincent T....> ;Leukemia. 2015 Aug 7
84 citations
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation
Nina Shah, Natalie S. Callander, Siddhartha Ganguly, Zartash Gul, Mehdi Hamadani, Luciano J. Costa, Salyka Sengsayadeth, Muneer H. Abidi, Parameswaran Hari, Mohamad Mo...> ;Biology of Blood and Marrow Transplantation. 2015 Jul 1
56 citations
Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma: Guidelines from the American Society for Blood and Marrow Trans...
Miguel-Angel Perales, Izaskun Ceberio, Philippe Armand, Linda J. Burns, Robert T. Chen, Peter D. Cole, Andrew M. Evens, Ginna G. Laport, Craig H. Moskowitz, Uday R. Po...> ;Biology of Blood and Marrow Transplantation. 2015 Jun 1
262 citations
Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations
Sergio Giralt, Luciano J. Costa, Jeffrey Schriber, John F. DiPersio, Richard T. Maziarz, John M. McCarty, Paul J. Shaughnessy, Edward L. Snyder, William I. Bensinger, ...> ;Biology of Blood and Marrow Transplantation. 2014 Mar 1
86 citations
Salvage Second Hematopoietic Cell Transplantation in Myeloma
Laura C. Michaelis, Ayman Saad, Xiaobo Zhong, Jennifer Le-Rademacher, Cesar O. Freytes, David I. Marks, Hillard M. Lazarus, Jennifer M. Bird, Leona Holmberg, Rammurti ...> ;Biology of Blood and Marrow Transplantation. 2013 May 1
59 citations
Multiple Myeloma, Version 1.2013
Kenneth C. Anderson, Melissa Alsina, William I. Bensinger, J. Sybil Biermann, Adam D. Cohen, Steven M. Devine, Benjamin Djulbegovic, Edward A. Faber, Cristina Gasparet...> ;Journal of the National Comprehensive Cancer Network. 2013 Jan 1
35 citations
Waldenström’s Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2013
Kenneth C. Anderson, Melissa Alsina, William Bensinger, J. Sybil Biermann, Adam D. Cohen, Steven M. Devine, Benjamin Djulbegovic, Edward A. Faber, Christine Gasparetto...> ;Journal of the National Comprehensive Cancer Network. 2012 Oct 1
417 citations
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.
Paul J. Martin, J. Douglas Rizzo, John R. Wingard, Karen K. Ballen, Peter T. Curtin, Corey Cutler, Mark R. Litzow, Yago Nieto, Bipin N. Savani, Jeffrey Schriber, Paul ...> ;Biology of Blood and Marrow Transplantation. 2012 Aug 1
180 citations
Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia
Wael Saber, Shaun R. Opie, J. Douglas Rizzo, Mei-Jie Zhang, Mary M. Horowitz, J. Schriber> ;Blood. 2012 Apr 26
13 citations
Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors
Mitchell E. Horwitz, Gwynn D. Long, Peter Holman, Edward N. Libby, G. Calandra, Jeffrey Schriber> ;Bone Marrow Transplantation. 2012 Feb 20
10 citations
Plerixafor 'just in time' for stem cell mobilization in a normal donor.
J. Schriber, V Fauble, L O Sproat, Adrienne D. Briggs> ;Bone Marrow Transplantation. 2011 Jul 1
63 citations
Second Unrelated Donor Hematopoietic Cell Transplantation for Primary Graft Failure
Jeffrey Schriber, Manza A. Agovi, Vincent T. Ho, Karen K. Ballen, Andrea Bacigalupo, Hillard M. Lazarus, Christopher Bredeson, Vikas Gupta, Richard T. Maziarz, Gregory...> ;Biology of Blood and Marrow Transplantation. 2010 Aug 1
12 citations
Preparing for Growth: Current Capacity and Challenges in Hematopoietic Stem Cell Transplantation Programs
Jeffrey R. Schriber, Claudio Anasetti, Helen E. Heslop, Alan K. Leahigh> ;Biology of Blood and Marrow Transplantation. 2010 May 1
178 citations
NCCN clinical practice guidelines in oncology: multiple myeloma.
Kenneth C. Anderson, M. Alsina, William I. Bensinger, Biermann Js, Asher A. Chanan-Khan, Adam D. Cohen, Steven M. Devine, Benjamin Djulbegovic, Cristina Gasparetto, Ca...> ;Journal of the National Comprehensive Cancer Network. 2009 Oct 1
Join now to see all

Lectures

Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Relapsed/Refractory Acute Myeloid Leukemia (AML)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

A Comprehensive Guide to Understanding Blood CancersNovember 2nd, 2017
Could Common Diabetes Drugs Help Fight Leukemia?September 2nd, 2015
What Is Hairy Cell Leukemia? Experts Explain This Rare Type of CancerSeptember 11th, 2021
Join now to see all

Professional Memberships

American Society of Hematology - ASH
Member
American Society for Blood and Marrow Transplantation
Member
American Society of Clinical Oncology - ASCO
Member
American College of Physicians - ACP
Member
Canadian Medical Association
Member
Royal College of Physicians and Surgeons
Member

Hospital Affiliations

City of Hope PhoenixGoodyear, Arizona
HonorHealth Scottsdale Shea Medical CenterScottsdale, Arizona
Chandler Regional Medical CenterChandler, Arizona
HonorHealth Scottsdale Osborn Medical CenterScottsdale, Arizona
HonorHealth Scottsdale Thompson Peak Medical CenterScottsdale, Arizona

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Aetna Whole Health Banner Health Network
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
Great West PPO
Health Net Arizona HMO
Health Net Arizona PPO/POS
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment